PMID- 34454377 OWN - NLM STAT- MEDLINE DCOM- 20211027 LR - 20211027 IS - 1872-6283 (Electronic) IS - 0379-0738 (Linking) VI - 327 DP - 2021 Oct TI - Expression of orexin-A (hypocretin-A) in the hypothalamus after traumatic brain injury: A postmortem evaluation. PG - 110961 LID - S0379-0738(21)00281-4 [pii] LID - 10.1016/j.forsciint.2021.110961 [doi] AB - Traumatic brain injury (TBI) is one of the leading causes of mortality and morbidity. The key component of TBI pathophysiology is traumatic axonal injury (TAI), commonly referred to as diffuse axonal injury (DAI). Coma is a serious complication which can occur following traumatic brain injury (TBI). Recently, studies have shown that the central orexinergic/ hypocretinergic system exhibit prominent arousal promoting actions. Therefore, the purpose of this study is to investigate by immunohistochemistry the expression of beta-amyloid precursor protein (beta-APP) in white matter of parasagittal region, corpus callosum and brainstem and the expression of orexin-A (ORXA) in the hypothalamus after traumatic brain injury. RESULTS: DAI was found in 26 (53.06%) cases, assessed with beta-APP immunohistochemical staining in parasagittal white matter, corpus callosum and brainstem. Orexin-A immunoreactivity in hypothalamus was completely absent in 5 (10.2%) of the cases; moderate reduction of ORXA was observed in 9 (18.4%) of the cases; and severe reduction was observed in 7 (14.3%) of the cases. A statistically significant correlation was found between beta-APP immunostaining in white matter, corpus callosum and brainstem in relation to survival time (p < 0.002, p < 0.003 and p < 0.005 respectively). A statistically positive correlation was noted between ORX-A immunoreactivity in hypothalamus to survival time (p < 0.003). An inverse correlation was noted between the expression of beta-APP in the regions of brain studied to the expression of ORX-A in the hypothalamus of the cases studied (p < 0.005). CONCLUSIONS: The present study demonstrated by immunohistochemistry that reduction of orexin-A neurons in the hypothalamus, involved in coma status and arousal, enhanced the immunoexpression of beta-APP in parasagital white matter, corpus callosum and brainstem. CI - Copyright (c) 2021 Elsevier B.V. All rights reserved. FAU - Kousi, Chrysavgi AU - Kousi C AD - Department of Forensic Medicine and Toxicology Health Sciences, School of Medicine, University of Ioannina, Greece. FAU - Lampri, Evangeli AU - Lampri E AD - Department of Pathology Health Sciences, School of Medicine, University of Ioannina, Greece. FAU - Voulgaris, Spyridon AU - Voulgaris S AD - Department of Neurosurgery, Health Sciences, School of Medicine, University of Ioannina, Greece. FAU - Vougiouklakis, Theodoros AU - Vougiouklakis T AD - Department of Forensic Medicine and Toxicology Health Sciences, School of Medicine, University of Ioannina, Greece. FAU - Galani, Vassiliki AU - Galani V AD - Department of Anatomy-Histology-Embryology, University of Ioannina, Greece. Electronic address: vgalani@uoi.gr. FAU - Mitselou, Antigony AU - Mitselou A AD - Department of Forensic Medicine and Toxicology Health Sciences, School of Medicine, University of Ioannina, Greece. LA - eng PT - Journal Article DEP - 20210819 PL - Ireland TA - Forensic Sci Int JT - Forensic science international JID - 7902034 RN - 0 (Amyloid beta-Protein Precursor) RN - 0 (Biomarkers) RN - 0 (Orexins) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Amyloid beta-Protein Precursor/*metabolism MH - Autopsy MH - Biomarkers/metabolism MH - Brain Injuries, Traumatic/*physiopathology MH - Brain Stem/metabolism MH - Corpus Callosum/metabolism MH - Diffuse Axonal Injury/diagnosis/*physiopathology MH - Female MH - Greece/epidemiology MH - Humans MH - Hypothalamus/*metabolism MH - Immunohistochemistry MH - Male MH - Middle Aged MH - Orexins/*metabolism MH - White Matter/metabolism OTO - NOTNLM OT - diffuse axonal injury OT - immunohistochemistry OT - orexin-A OT - traumatic brain injury OT - beta-APP EDAT- 2021/08/29 06:00 MHDA- 2021/10/28 06:00 CRDT- 2021/08/28 20:25 PHST- 2021/02/17 00:00 [received] PHST- 2021/04/16 00:00 [revised] PHST- 2021/08/17 00:00 [accepted] PHST- 2021/08/29 06:00 [pubmed] PHST- 2021/10/28 06:00 [medline] PHST- 2021/08/28 20:25 [entrez] AID - S0379-0738(21)00281-4 [pii] AID - 10.1016/j.forsciint.2021.110961 [doi] PST - ppublish SO - Forensic Sci Int. 2021 Oct;327:110961. doi: 10.1016/j.forsciint.2021.110961. Epub 2021 Aug 19.